Insulin was the preferred medication for 98.13% (157) T1DM participants to manage glycemic control; 52.5% (84) used antihypertensive medication; and 53.75% (86) used statins to treat low HDL-C or high TG levels. This evidence concerns the gene INS and type 1 diabetes mellitus.